Evidence-Based Medicine Guidelines
Interferon alpha for the adjuvant treatment of cutaneous melanoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interferon Alpha for the Adjuvant Treatment of Cutaneous Melanoma." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452015/all/Interferon_alpha_for_the_adjuvant_treatment_of_cutaneous_melanoma.
Interferon alpha for the adjuvant treatment of cutaneous melanoma. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452015/all/Interferon_alpha_for_the_adjuvant_treatment_of_cutaneous_melanoma. Accessed September 20, 2024.
Interferon alpha for the adjuvant treatment of cutaneous melanoma. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452015/all/Interferon_alpha_for_the_adjuvant_treatment_of_cutaneous_melanoma
Interferon Alpha for the Adjuvant Treatment of Cutaneous Melanoma [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 September 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452015/all/Interferon_alpha_for_the_adjuvant_treatment_of_cutaneous_melanoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interferon alpha for the adjuvant treatment of cutaneous melanoma
ID - 452015
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452015/all/Interferon_alpha_for_the_adjuvant_treatment_of_cutaneous_melanoma
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
